Adults with obesity (body mass index ≥30 kg/m<sup>2</sup> or ICD-10-CM diagnosis codes) who initiated tirzepatide or GLP-1 RAs between January 2022 and August 2025 were identified. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.